In vitro release of soluble CD23 by human lymphocytes in ragweed-sensitive versus nonatopic patients following stimulation with ragweed antigen E

被引:2
作者
Batterman, J [1 ]
Mazza, DS [1 ]
Meriney, DK [1 ]
Cleveland, WL [1 ]
Reddy, MM [1 ]
Grieco, MH [1 ]
机构
[1] COLUMBIA UNIV,ST LUKES ROOSEVELT HOSP CTR,RA COOKE INST ALLERGY,NEW YORK,NY 10019
关键词
D O I
10.1016/S1081-1206(10)60038-5
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Soluble CD23 is the proteolytic cleavage product of the low affinity receptor (FcERII). Functions of CD23 and its soluble products may include upregulation of IgE production and stimulation of B lymphocyte growth. Methods: Soluble CD23 was quantitated in supernatants of lymphocytes from nine ragweed-sensitive and eight nonatopic subjects stimulated in vitro by antigen E lamb A1), crude ragweed extract, and pokeweed mitogen (PWM). Results: Although PWM stimulation produced no significant difference between groups, sCD23 release was significantly E and crude ragweed extract. (P <.05) Conclusions: This finding supports the concept of separate pathways of activation by antigen and mitogen for sCD23 release and suggests ragweed-sensitive and nonatopic patients have fundamental differences in the response of sCD23 release to stimulation.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 18 条
[1]  
BEGUIN Y, 1993, LEUKEMIA, V7, P2019
[2]  
BONNEFOY JY, 1933, IMMUNOL TODAY, V14, P1
[3]   LYMPHOCYTE-RESPONSES TO PURIFIED RAGWEED ALLERGENS INVITRO .1. PROLIFERATIVE RESPONSES IN NORMAL, NEWBORN, AGAMMAGLOBULINEMIC, AND ATOPIC SUBJECTS [J].
BUCKLEY, RH ;
SEYMOUR, F ;
SANAL, SO ;
OWNBY, DR ;
BECKER, WG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1977, 59 (01) :70-78
[4]   INCREASED PRODUCTION OF SOLUBLE CD23 IN RHEUMATOID-ARTHRITIS, AND ITS REGULATION BY INTERLEUKIN-4 [J].
CHOMARAT, P ;
BRIOLAY, J ;
BANCHEREAU, J ;
MIOSSEC, P .
ARTHRITIS AND RHEUMATISM, 1993, 36 (02) :234-242
[5]  
CORIMINAS M, 1993, CLIN EXP ALLERGY, V23, P612
[6]   HUMAN IGE-BINDING FACTORS [J].
DELESPESSE, G ;
SARFATI, M ;
HOFSTETTER, H .
IMMUNOLOGY TODAY, 1989, 10 (05) :159-164
[7]   SOLUBLE CD23 AS AN EFFECTOR OF IMMUNE DYSREGULATION IN CHRONIC UREMIA AND DIALYSIS [J].
DESCAMPSLATSCHA, B ;
HERBELIN, A ;
NGUYEN, AT ;
DEGROOTE, D ;
CHAUVEAU, P ;
VERGER, C ;
JUNGERS, P ;
ZINGRAFF, J .
KIDNEY INTERNATIONAL, 1993, 43 (04) :878-884
[8]   INTERLEUKIN-4 AND SOLUBLE CD23 AS PROGRESSION FACTORS FOR HUMAN LYMPHOCYTES-B - ANALYSIS OF THEIR INTERACTIONS WITH AGONISTS OF THE PHOSPHOINOSITIDE DUAL PATHWAY OF SIGNALING [J].
GORDON, J ;
CAIRNS, JA ;
MILLSUM, MJ ;
GILLIS, S ;
GUY, GR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1561-1565
[9]  
KAWABE T, 1991, J IMMUNOL, V147, P548
[10]  
KICZA K, 1989, IMMUNOLOGY, V68, P523